Lilly joins the push for non-opioid painkillers
Eli Lilly acquires exclusive worldwide rights for non-opioid treatment for chronic pain from Centrexion through a licensing agreement.
Archives for June 3, 2019
PE firm Ampersand acquires German CDMO Vibalogics
The private equity firm Ampersand Capital has acquired Vibalogics with plans to increase development and manufacturing capabilities for complex viral products.
Scientist.com teams up with VC firm to create marketplace for biotech
The online marketplace for outsourced R&D services Scientist.com partners with 5AM Ventures to help researchers save time and money – as the industry is "caught between a rock and a hard place," says CEO.
Lonza to carve-out and trim down Specialty Ingredients business
Lonza announces that its Specialty Ingredients business will operate independently by ‘mid-2020’ and will cut away approximately 130 roles at the same time.
Catalent unveils OneBio Suite for biologics development
Catalent is unveiling its OneBio Suite for the integrated development, manufacturing, and clinical supply of biologic drugs.
FDA mulls fixed-quantity packaging stipulation for opioids
US FDA considers demanding opioid manufacturers to package treatments in 5-, 10-, or 15-count blisters to reduce the risk of harm.